Skip to main content
. 2022 Mar 17;14(3):220. doi: 10.3390/toxins14030220

Figure 6.

Figure 6

Characterization of ZEN mAbs obtained in this study: (a) analysis of the subtypes of ZEN mAbs 2B6, 4D9, 1A10, and 4G8; (b) affinity constant (Ka) of ZEN mAbs 2B6, 4D9, 1A10, and 4G8; (c) the titer values of ZEN mAbs 2B6, 4D9, 1A10, and 4G8 at different times; (d) the IC50 values of ZEN mAbs 2B6, 4D9, 1A10, and 4G8 at different times.